Genetic pathways to autism spectrum disorders

Neuropsychiatry

Volumn 3, Issue 2, 2013, Pages 193-207

  Mehta, Sunil Q ^a   Nurmi, Erika L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

ALLELE; AUTISM; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME 15Q; CHROMOSOME ABERRATION; CLINICAL FEATURE; COPY NUMBER VARIATION; DNA METHYLATION; ENDOPHENOTYPE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HERITABILITY; HUMAN; MOLECULAR DIAGNOSIS; PATHOPHYSIOLOGY; PHENOTYPE; PRENATAL EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; QUANTITATIVE TRAIT LOCUS MAPPING; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84876120280     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.13.16     Document Type: Review

References (178)

1. American Psychiatric Association. Diagnostic and Statistical Manual Of Mental Disorders (Revised 4th Edition). American Psychiatric Association, Washington, DC, USA (2000).
2. Autism and Developmental Disabilities Monitoring Network, Centers for Disease Control. Prevalence of autism spectrum disorders -Autism And Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill. Summ. 61(3), 1-19 (2012).
3. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders -Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill. Summ. 58(10), 1-20 (2009).
4. Fombonne E, Quirke S, Hagen A. Prevalence and interpretation of recent trends in rates of pervasive developmental disorders. McGill J. Med. 12(2), 73 (2009).
5. Croen LA, Grether JK, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J. Autism Dev. Disord. 32(3), 207-215 (2002).
6. Hertz-Picciotto I, Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology 20(1), 84-90 (2009).
7. Croen LA, Najjar DV, Fireman B, Grether JK. Maternal and paternal age and risk of autism spectrum disorders. Arch. Pediatr. Adolesc. Med. 161(4), 334-340 (2007).
8. Durkin MS, Maenner MJ, Newschaffer CJ, et al. Advanced parental age and the risk of autism spectrum disorder. Am. J. Epidemiol. 168(11), 1268-1276 (2008).
9. Shelton JF, Tancredi DJ, Hertz-Picciotto I. Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res. 3(1), 30-39 (2010).
10. Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex differences in the brain: implications for explaining autism. Science 310(5749), 819-823 (2005).
11. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R. Why are autism spectrum conditions more prevalent in males? PLoS Biol. 9(6), e1001081 (2011).
12. Sutcliffe JS, Nurmi EL, Lombroso PJ. Genetics of childhood disorders: XLVII. Autism, part 6: duplication and inherited susceptibility of chromosome 15q11-q13 genes in autism. J. Am. Acad. Child Adolesc. Psychiatry 42(2), 253-256 (2003).
13. Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B(3), 255-274 (2011).
14. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25(1), 63-77 (1995).
15. Ritvo ER, Freeman BJ, Mason-Brothers A, Mo A, Ritvo AM. Concordance for the syndrome of autism in 40 pairs of afflicted twins. Am. J. Psychiatry 142(1), 74-77 (1985).
16. Steffenburg S, Gillberg C, Hellgren L, et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J. Child Psychol. Psychiatry 30(3), 405-416 (1989).
17. Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68(11), 1095-1102 (2011).
18. Lichtenstein P, Carlstrom E, Rastam M, Gillberg C, Anckarsater H. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am. J. Psychiatry 167(11), 1357-1363 (2010).
19. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am. J. Psychiatry 162(6), 1133-1141 (2005).
20. Icasiano F, Hewson P, Machet P, Cooper C, Marshall A. Childhood autism spectrum disorder in the Barwon region: a community based study. J. Paediatr. Child Health 40(12), 696-701 (2004).
21. Lauritsen MB, Pedersen CB, Mortensen PB. Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study. J. Child Psychol. Psychiatry 46(9), 963-971 (2005).
22. Ozonoff S, Young GS, Carter A, et al. Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics doi:10.1542/peds.2010-2825 (2011).
23. Chess S. Autism in children with congenital rubella. J. Autism Child Schizophr. 1(1), 33-47 (1971).
24. Deykin EY, Macmahon B. Viral exposure and autism. Am. J. Epidemiol. 109(6), 628-638 (1979).
25. Rasalam AD, Hailey H, Williams JH, et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev. Med. Child Neurol. 47(8), 551-555 (2005).
26. Atladottir HO, Henriksen TB, Schendel DE, Parner ET. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics 130(6), e1447-e1454 (2012).
27. Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R. Residential proximity to freeways and autism in the CHARGE Study. Environ. Health Perspect. 119(6), 873-877 (2011).
28. Baird G, Pickles A, Simonoff E, et al. Measles vaccination and antibody response in autism spectrum disorders. Arch. Dis. Child 93(10), 832-837 (2008).
29. Deer B. How the case against the MMR vaccine was fixed. BMJ 342, c5347 (2011).
30. Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Vaccine 30(28), 4292-4298 (2012).
31. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82(2), 477-488 (2008).
32. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 1380, 42-77 (2011).
33. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science 316(5823), 445-449 (2007).
34. Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70(5), 863-885 (2011).
35. Fischbach GD, Lord C. The Simons Simplex Collection: a resource for identification of autism genetic risk factors. Neuron 68(2), 192-195 (2010).
36. Kumar RA, Karamohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 17(4), 628-638 (2008).
37. Bucan M, Abrahams BS, Wang K, et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 5(6), e1000536 (2009).
38. Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466(7304), 368-372 (2010).
39. Levy D, Ronemus M, Yamrom B, et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70(5), 886-897 (2011).
40. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70(5), 898-907 (2011).
41. Stankiewicz P, Lupski Jr. Structural variation in the human genome and its role in disease. Annu. Rev. Med. 61, 437-455 (2010).
42. Auranen M, Vanhala R, Varilo T, et al. A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. Am. J. Hum. Genet. 71(4), 777-790 (2002).
43. International Molecular Genetic Study of Autism Consortium. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am. J. Hum. Genet. 69(3), 570-581 (2001).
44. Yonan AL, Alarcon M, Cheng R, et al. A genomewide screen of 345 families for autism-susceptibility loci. Am. J. Hum. Genet. 73(4), 886-897 (2003).
45. Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature 461(7265), 802-808 (2009).
46. Badner JA, Gershon ES. Regional meta-analysis of published data supports linkage of autism with markers on chromosome 7. Mol. Psychiatry 7(1), 56-66 (2002).
47. Cantor RM, Kono N, Duvall JA, et al. Replication of autism linkage: fine-mapping peak at 17q21. Am. J. Hum. Genet. 76(6), 1050-1056 (2005).
48. Stone JL, Merriman B, Cantor RM, Geschwind DH, Nelson SF. High density SNP association study of a major autism linkage region on chromosome 17. Hum. Mol. Genet. 16(6), 704-715 (2007).
49. Strom SP, Stone JL, Ten Bosch JR, et al. High-density SNP association study of the 17q21 chromosomal region linked to autism identifies CACNA1G as a novel candidate gene. Mol. Psychiatry 15(10), 996-1005 (2010).
50. Stone JL, Merriman B, Cantor RM, et al. Evidence for sex-specific risk alleles in autism spectrum disorder. Am. J. Hum. Genet. 75(6), 1117-1123 (2004).
51. Molloy CA, Keddache M, Martin LJ. Evidence for linkage on 21q and 7q in a subset of autism characterized by developmental regression. Mol. Psychiatry 10(8), 741-746 (2005).
52. Salyakina D, Ma DQ, Jaworski JM, et al. Variants in several genomic regions associated with asperger disorder. Autism Res. 3(6), 303-310 (2010).
53. Nurmi EL, Dowd M, Tadevosyan-Leyfer O, Haines JL, Folstein SE, Sutcliffe JS. Exploratory subsetting of autism families based on savant skills improves evidence of genetic linkage to 15q11-q13. J. Am. Acad. Child Adolesc. Psychiatry 42(7), 856-863 (2003).
54. Vieland VJ, Hallmayer J, Huang Y, et al. Novel method for combined linkage and genome-wide association analysis finds evidence of distinct genetic architecture for two subtypes of autism. J. Neurodev. Disord. 3(2), 113-123 (2011).
55. Chasson GS, Timpano KR, Greenberg JL, Shaw A, Singer T, Wilhelm S. Shared social competence impairment: another link between the obsessive-compulsive and autism spectrums? Clin. Psychol. Rev. 31(4), 653-662 (2011).
56. Delorme R, Gousse V, Roy I, et al. Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive-compulsive disorder. Eur. Psychiatry 22(1), 32-38 (2007).
57. Rommelse NN, Geurts HM, Franke B, Buitelaar JK, Hartman CA. A review on cognitive and brain endophenotypes that may be common in autism spectrum disorder and attention-deficit/hyperactivity disorder and facilitate the search for pleiotropic genes. Neurosci. Biobehav. Rev. 35(6), 1363-1396 (2011).
58. Scott-Van Zeeland AA, Abrahams BS, Alvarez-Retuerto AI, et al. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci. Transl. Med. 2(56), 56ra80 (2010).
59. Losh M, Adolphs R, Poe MD, et al. Neuropsychological profile of autism and the broad autism phenotype. Arch. Gen. Psychiatry 66(5), 518-526 (2009).
60. Constantino JN. The quantitative nature of autistic social impairment. Pediatr. Res. 69(5 Pt 2), 55R-62R (2011).
61. Sung YJ, Dawson G, Munson J, Estes A, Schellenberg GD, Wijsman EM. Genetic investigation of quantitative traits related to autism: use of multivariate polygenic models with ascertainment adjustment. Am. J. Hum. Genet. 76(1), 68-81 (2005).
62. Robinson EB, Munir K, Munafo MR, Hughes M, Mccormick MC, Koenen KC. Stability of autistic traits in the general population: further evidence for a continuum of impairment. J. Am. Acad. Child Adolesc. Psychiatry 50(4), 376-384 (2011).
63. Robinson EB, Koenen KC, Mccormick MC, et al. Evidence that autistic traits show the same etiology in the general population and at the quantitative extremes (5%, 2.5%, and 1%). Arch. Gen. Psychiatry 68(11), 1113-1121 (2011).
64. Chapman NH, Estes A, Munson J, et al. Genome-scan for IQ discrepancy in autism: evidence for loci on chromosomes 10 and 16. Hum. Genet. 129(1), 59-70 (2011).
65. Liu XQ, Georgiades S, Duku E, et al. Identification of genetic loci underlying the phenotypic constructs of autism spectrum disorders. J. Am. Acad. Child Adolesc. Psychiatry 50(7), 687e613-696e613 (2011).
66. Cho SC, Yoo HJ, Park M, et al. Genome-wide association scan of korean autism spectrum disorders with language delay: a preliminary study. Psychiatry Investig. 8(1), 61-66 (2011).
67. Wheelwright S, Auyeung B, Allison C, Baron-Cohen S. Defining the broader, medium and narrow autism phenotype among parents using the Autism Spectrum Quotient (AQ). Mol. Autism 1(1), 10 (2010).
68. Anney RJ, Kenny EM, O'Dushlaine C, et al. Gene-ontology enrichment analysis in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders. Eur. J. Hum. Genet. 19(10), 1082-1089 (2011).
69. Bill BR, Geschwind DH. Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr. Opin. Genet. Dev. 19(3), 271-278 (2009).
70. Geschwind DH. Autism: many genes, common pathways? Cell 135(3), 391-395 (2008).
71. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474(7351), 380-384 (2011).
72. Wang K, Zhang H, Ma D, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459(7246), 528-533 (2009).
73. Anney R, Klei L, Pinto D, et al. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 19(20), 4072-4082 (2010).
74. Pelak K, Shianna KV, Ge D, et al. The characterization of twenty sequenced human genomes. PLoS Genet. 6(9), e1001111. (2010).
75. Abecasis GR, Auton A, et al.; The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422), 56-65 (2012).
76. Iossifov I, Ronemus M, Levy D, et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74(2), 285-299 (2012).
77. Pennisi E. Genomics. ENCODE project writes eulogy for junk DNA. Science 337(6099), 1159-1161 (2012).
78. Macarthur DG, Tyler-Smith C. Loss-of-function variants in the genomes of healthy humans. Hum. Mol. Genet. 19(R2), R125-R130 (2010).
79. Kong A, Frigge ML, Masson G, et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488(7412), 471-475 (2012).
80. O'Roak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485(7397), 246-250 (2012).
81. Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485(7397), 237-241 (2012).
82. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485(7397), 242-245 (2012).
83. Ben-David E, Shifman S. Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol. Psychiatry doi:10.1038/mp.2012.148 (2012) (Epub ahead of print).
84. Shi X, Yasumoto S, Kurahashi H, et al. Clinical spectrum of SCN2A mutations. Brain Dev. 34(7), 541-545 (2012).
85. Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc. Natl Acad. Sci. USA 106(45), 19096-19101 (2009).
86. Hu VW, Addington A, Hyman A. Novel autism subtype-dependent genetic variants are revealed by quantitative trait and subphenotype association analyses of published GWAS data. PLoS One 6(4), e19067 (2011).
87. Chahrour MH, Yu TW, Lim ET, et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet. 8(4), e1002635 (2012).
88. Girirajan S, Rosenfeld JA, Cooper GM, et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat. Genet. 42(3), 203-209 (2010).
89. Klei L, Sanders SJ, Murtha MT, et al. Common genetic variants, acting additively, are a major source of risk for autism. Mol. Autism 3(1), 9 (2012).
90. Leblond CS, Heinrich J, Delorme R, et al. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet. 8(2), e1002521 (2012).
91. Schaaf CP, Sabo A, Sakai Y, et al. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum. Mol. Genet. 20(17), 3366-3375 (2011).
92. Hanson E, Nasir RH, Fong A, et al. Cognitive and behavioral characterization of 16p11.2 deletion syndrome. J. Dev. Behav. Pediatr. 31(8), 649-657 (2010).
93. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358(7), 667-675 (2008).
94. Mccarthy SE, Makarov V, Kirov G, et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat. Genet. 41(11), 1223-1227 (2009).
95. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 86(5), 749-764 (2010).
96. American Academy of Pediatrics. Autism Caring for Children With Autism Spectrum Disorder.A Resource Toolkit for Clinicians (2nd Edition). American Academy of Pediatrics, IL, USA (2013).
97. Mcgrew SG, Peters BR, Crittendon JA, Veenstra-Vanderweele J. Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement? J. Autism Dev. Disord. 42(8), 1582-1591 (2012).
98. Shen Y, Dies KA, Holm IA, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 125(4), e727-e735 (2010).
99. Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics 120(5), 1183-1215 (2007).
100. Bissler JJ, Mccormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 358(2), 140-151 (2008).
101. Franz DN, Belousova E, Sparagana S, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled Phase 3 trial. Lancet 381(9861), 125-132 (2013).
102. Berry-Kravis E, Hessl D, Coffey S, et al. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J. Med. Genet. 46(4), 266-271 (2009).
103. Geschwind DH. Advances in autism. Annu. Rev. Med. 60, 367-380 (2009).
104. Grissom NM, Reyes TM. Gestational overgrowth and undergrowth affect neurodevelopment: similarities and differences from behavior to epigenetics. Int. J. Dev. Neurosci., (2012).
105. Wang T, Pan Q, Lin L, et al. Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum. Hum. Mol. Genet. 21(26), 5500-5510 (2012).
106. Shulha HP, Cheung I, Whittle C, et al. Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons. Arch. Gen. Psychiatry 69(3), 314-324 (2012).
107. Ginsberg MR, Rubin R A, Falcone T, Ting AH, Natowicz MR. Brain transcriptional and epigenetic associations with autism. PLoS ONE 7(9), e44736 (2012).
108. Mefford HC, Sharp AJ, Baker C, et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med.359(16), 1685-1699 (2008).
109. Szatmari P, Paterson AD, Zwaigenbaum L, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39(3), 319-328 (2007).
110. Fernandez T, Morgan T, Davis N, et al. Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am. J. Hum. Genet. 74(6), 1286-1293 (2004).
111. Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459(7246), 569-573 (2009).
112. Roohi J, Montagna C, Tegay DH, et al. Disruption of contactin 4 in three subjects with autism spectrum disorder. J. Med. Genet. 46(3), 176-182 (2009).
113. Jackman C, Horn ND, Molleston JP, Sokol DK. Gene associated with seizures, autism, and hepatomegaly in an Amish girl. Pediatr. Neurol. 40(4), 310-313 (2009).
114. Poot M, Beyer V, Schwaab I, et al. Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 11(1), 81-89 (2010).
115. Strauss KA, Puffenberger EG, Huentelman MJ, et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 354(13), 1370-1377 (2006).
116. Orrico A, Galli L, Buoni S, Orsi A, Vonella G, Sorrentino V. Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clin. Genet. 75(2), 195-198 (2009).
117. Varga EA, Pastore M, Prior T, Herman GE, Mcbride KL. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet. Med. 11(2), 111-117 (2009).
118. Kent L, Bowdin S, Kirby GA, Cooper WN, Maher ER. Beckwith Weidemann syndrome: a behavioral phenotype-genotype study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B(7), 1295-1297 (2008).
119. Tierney E, Nwokoro NA, Porter FD, Freund LS, Ghuman JK, Kelley RI. Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. 98(2), 191-200 (2001).
120. Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119(1), 19-31 (2004).
121. Splawski I, Yoo DS, Stotz SC, Cherry A, Clapham DE, Keating MT. CACNA1H mutations in autism spectrum disorders. J. Biol. Chem. 281(31), 22085-22091 (2006).
122. Cook EH Jr, Lindgren V, Leventhal BL, et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 60(4), 928-934 (1997).
123. Depienne C, Moreno-De-Luca D, Heron D, et al. Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol. Psychiatry 66(4), 349-359 (2009).
124. Ben-Shachar S, Lanpher B, German JR, et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J. Med. Genet. 46(6), 382-388 (2009).
125. Sharp AJ, Mefford HC, Li K, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat. Genet. 40(3), 322-328 (2008).
126. Bonati MT, Russo S, Finelli P, et al. Evaluation of autism traits in Angelman syndrome: a resource to unfold autism genes. Neurogenetics 8(3), 169-178 (2007).
127. Peters SU, Beaudet AL, Madduri N, Bacino CA. Autism in Angelman syndrome: implications for autism research. Clin. Gen. 66(6), 530-536 (2004).
128. Descheemaeker MJ, Govers V, Vermeulen P, Fryns JP. Pervasive developmental disorders in Prader-Willi syndrome: the Leuven experience in 59 subjects and controls. Am. J. Med. Genet. A 140(11), 1136-1142 (2006).
129. Potocki L, Bi W, Treadwell-Deering D, et al. Characterization of Potocki-Lupski syndrome (dup[17][p11.2p11.2]) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am. J. Hum. Genet. 80(4), 633-649 (2007).
130. Treadwell-Deering DE, Powell MP, Potocki L. Cognitive and behavioral characterization of the Potocki-Lupski syndrome (duplication 17p11.2). J. Dev. Behav. Pediatr. 31(2), 137-143 (2010).
131. Fine SE, Weissman A, Gerdes M, et al. Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J. Autism Dev. Disord. 35(4), 461-470 (2005).
132. Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res. Dev. Disabil. 30(4), 763-773 (2009).
133. Vorstman JA, Morcus ME, Duijff SN, et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J. Am. Acad. Child Adolesc. Psychiatry 45(9), 1104-1113 (2006).
134. Manning MA, Cassidy SB, Clericuzio C, et al. Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics 114(2), 451-457 (2004).
135. Moessner R, Marshall CR, Sutcliffe JS, et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81(6), 1289-1297 (2007).
136. Diguiseppi C, Hepburn S, Davis JM, et al. Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening test characteristics. J. Dev. Behav. Pediatr. 31(3), 181-191 (2010).
137. Lowenthal R, Paula CS, Schwartzman JS, Brunoni D, Mercadante MT. Prevalence of pervasive developmental disorder in Down's syndrome. J. Autism Dev. Disord. 37(7), 1394-1395 (2007).
138. Hatton DD, Sideris J, Skinner M, et al. Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP. Am. J. Med. Genet. A 140A(17), 1804-1813 (2006).
139. Winarni TI, Utari A, Mundhofir FE, Hagerman RJ, Faradz SM. Fragile X syndrome: clinical, cytogenetics and molecular screening among autism spectrum disorder children in Indonesia. Clin. Genet. doi:10.1111/cge.12095 (2013) (Epub ahead of print).
140. Ehninger D, Silva AJ. Rapamycin for treating tuberous sclerosis and autism spectrum disorders.Trends Mol. Med. 17(2), 78-87 (2011).
141. Liu E, Knutzen CA, Krauss S, Schweiger S, Chiang GG. Control of mTORC1 signaling by the Opitz syndrome protein MID1. Proc. Natl Acad. Sci. USA 108(21), 8680-8685 (2011).
142. Ji H, Wang Z, Perera SA, et al. Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models. Cancer Res. 67(10), 4933-4939 (2007).
143. Bandyopadhyay S, Chiang CY, Srivastava J, et al. A human MAP kinase interactome. Nat. Methods 7(10), 801-805 (2010).
144. Choi YB, Li HL, Kassabov SR, et al. Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in aplysia. Neuron 70(3), 468-481 (2011).
145. Kim JE, O'Sullivan ML, Sanchez CA, et al. Investigating synapse formation and function using human pluripotent stem cell-derived neurons. Proc. Natl Acad. Sci. USA 108(7), 3005-3010 (2011).
146. Shoubridge C, Walikonis RS, Gecz J, Harvey RJ. Subtle functional defects in the Arf-specific guanine nucleotide exchange factor IQSEC2 cause non-syndromic X-linked intellectual disability. Small GTPases 1(2), 98-103 (2010).
147. Grabrucker AM, Knight MJ, Proepper C, et al. Concerted action of zinc and ProSAP/ Shank in synaptogenesis and synapse maturation. EMBO J. 30(3), 569-581 (2011).
148. Atasoy D, Schoch S, Ho A, et al. Deletion of CASK in mice is lethal and impairs synaptic function. Proc. Natl Acad. Sci. USA 104(7), 2525-2530 (2007).
149. Daoud F, Candelario-Martinez A, Billard JM, et al. Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions. PLoS ONE 4(8), e6574 (2009).
150. Ronesi JA, Collins KA, Hays SA, et al. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat. Neurosci. 15(3), 431-440, S431 (2012).
151. Auerbach BD, Osterweil EK, Bear MF. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480(7375), 63-68 (2011).
152. Melko M, Douguet D, Bensaid M, et al. Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability. Hum. Mol. Genet. 20(10), 1873-1885 (2011).
153. Lee JA, Tang ZZ, Black DL. An inducible change in Fox-1/A2BP1 splicing modulates the alternative splicing of downstream neuronal target exons. Genes Dev. 23(19), 2284-2293 (2009).
154. Ricciardi S, Kilstrup-Nielsen C, Bienvenu T, Jacquette A, Landsberger N, Broccoli V. CDKL5 influences RNA splicing activity by its association to the nuclear speckle molecular machinery. Hum. Mol. Genet. 18(23), 4590-4602 (2009).
155. Chamieh H, Ballut L, Bonneau F, Le Hir H. NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity. Nat. Struct. Mol. Biol. 15(1), 85-93 (2008).
156. Tapia VE, Nicolaescu E, Mcdonald CB, et al. Y65C missense mutation in the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1 affects its binding activity and deregulates pre-mRNA splicing. J. Biol. Chem. 285(25), 19391-19401 (2010).
157. Schenck A, Bardoni B, Moro A, Bagni C, Mandel JL. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc. Natl Acad. Sci. USA 98(15), 8844-8849 (2001).
158. Fogel BL, Wexler E, Wahnich A, et al. RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum. Mol. Genet. 21(19), 4171-4186 (2012).
159. Lucio-Eterovic AK, Singh MM, Gardner JE, Veerappan CS, Rice JC, Carpenter PB. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function. Proc. Natl Acad. Sci. USA 107(39), 16952-16957 (2010).
160. Iwase S, Lan F, Bayliss P, et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128(6), 1077-1088 (2007).
161. Kleine-Kohlbrecher D, Christensen J, Vandamme J, et al. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol. Cell 38(2), 165-178 (2010).
162. Srinivasan S, Dorighi KM, Tamkun JW. Drosophila Kismet regulates histone H3 lysine 27 methylation and early elongation by RNA polymerase II. PLoS Genet. 4(10), e1000217 (2008).
163. Kramer JM, Kochinke K, Oortveld MA, et al. Epigenetic regulation of learning and memory by Drosophila EHMT/G9a. PLoS Biol. 9(1), e1000569 (2011).
164. Kagey MH, Newman JJ, Bilodeau S, et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature 467(7314), 430-435 (2010).
165. Kernohan KD, Jiang Y, Tremblay DC, et al. ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Dev. Cell 18(2), 191-202 (2010).
166. Mikhail FM, Lose EJ, Robin NH, et al. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. Am. J. Med. Genet. A 155A(10), 2386-2396 (2011).
167. Morrow EM, Yoo SY, Flavell SW, et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321(5886), 218-223 (2008).
168. Gharani N, Benayed R, Mancuso V, Brzustowicz LM, Millonig JH. Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol. Psychiatry 9(5), 474-484 (2004).
169. Choi J, Ababon MR, Matteson PG, Millonig JH. Cut-like homeobox 1 and nuclear factor I/B mediate ENGRAILED2 autism spectrum disorder-associated haplotype function. Hum. Mol. Genet. 21(7), 1566-1580 (2012).
170. Tischfield MA, Bosley TM, Salih MA, et al. Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development. Nat. Genet. 37(10), 1035-1037 (2005).
171. Talkowski ME, Rosenfeld JA, Blumenthal I, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149(3), 525-537 (2012).
172. O'Roak BJ, Deriziotis P, Lee C, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat. Genet. 43(6), 585-589 (2011).
173. Laje G, Morse R, Richter W, Ball J, Pao M, Smith AC. Autism spectrum features in Smith-Magenis syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 154C(4), 456-462 (2010).
174. Marsh E, Fulp C, Gomez E, et al. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 132(Pt 6), 1563-1576 (2009).
175. Turner G, Partington M, Kerr B, Mangelsdorf M, Gecz J. Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation. Am. J. Med. Genet. 112(4), 405-411 (2002).
176. Chen YZ, Matsushita M, Girirajan S, et al. Evidence for involvement of GNB1L in autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B(1), 61-71 (2012).
177. Paylor R, Glaser B, Mupo A, et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl Acad. Sci. USA 103(20), 7729-7734 (2006).
178. SFARI gene home. http://gene.sfari.org